Actual Medicinal Product (AMP) Chlordiazepoxide 5mg capsules (Phoenix Healthcare Distribution Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Librium 5mg capsules (Mylan) and Chlordiazepoxide 5mg capsules (Kent Pharmaceuticals Limited).
- Generic
- Chlordiazepoxide
- Formulation
- Chlordiazepoxide 5mg capsules
-
Chlordiazepoxide
-
Chlordiazepoxide 5mg capsules
-
Chlordiazepoxide 5mg capsules (Phoenix Healthcare Distribution Ltd)
-
-
Chlordiazepoxide 10mg tablets